Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

225 projects found matching your search criteria :

  1. Maternal obesity as a risk factor of autism spectrum disorder in offspring - in search of the role of the gut microbiota...

    Call: OPUS 22 , Panel: NZ5

    Principal investigator: dr Dawid Gawliński

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  2. Photoswitchable and chimeric molecules for spatially restricted and endoplasmic reticulum-specific blockade of PD-L1 pro...

    Call: SONATA BIS 11 , Panel: NZ7

    Principal investigator: dr Łukasz Skalniak

    Uniwersytet Jagielloński, Wydział Chemii

  3. New synthetic resveratrol derivatives with potential anti-ageing and anti-cancer properties

    Call: PRELUDIUM 2 , Panel: NZ7

    Principal investigator: dr Justyna Mikuła-Pietrasik

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Lekarski II

  4. The relationship between hostile attributions and personality disorders symptoms: contextual and cognitive underpinnings...

    Call: SONATA BIS 11 , Panel: HS6

    Principal investigator: dr hab. Anna Zajenkowska

    Akademia Pedagogiki Specjalnej im. Marii Grzegorzewskiej

  5. 3D printing as a tool to obtain transdermal microneedle systems with improved efficiency in the treatment of depressive ...

    Call: SONATA BIS 11 , Panel: NZ7

    Principal investigator: dr hab. Tomasz Osmałek

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

  6. Novel hope for diseased joints: a polymer-based treatment to promoteregenerative strategies for patients with osteoarthr...

    Call: PRELUDIUM 20 , Panel: NZ7

    Principal investigator: Marta Kędziora

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  7. Hybrid isothermal annealing as innovative heat treatment of nanobainitic multiphase steels with yield strength > 1GPa

    Call: PRELUDIUM 20 , Panel: ST8

    Principal investigator: Mateusz Morawiec

    Politechnika Śląska, Wydział Mechaniczny Technologiczny

  8. Bioabsorbable hydroxyapatite/polymer nanocomposite granules with enhanced osteoconductivity and anti-inflammatory proper...

    Call: PRELUDIUM 20 , Panel: NZ7

    Principal investigator: Vladyslav Vivcharenko

    Uniwersytet Medyczny w Lublinie

  9. Anticancer activity of novel derivatives of 9,10-Anthraquinone Dithiocarbamates

    Call: PRELUDIUM 20 , Panel: NZ7

    Principal investigator: Natalia Maciejewska

    Politechnika Gdańska

  10. The role of miR-27b-5p in Head and Neck Squamous Cell Carcinoma.

    Call: PRELUDIUM 20 , Panel: NZ5

    Principal investigator: Joanna Kozłowska

    Wielkopolskie Centrum Onkologii im. Marii Skłodowskiej-Curie

  11. Comprehensive research of the Bifidobacterium lipoteichoic acids - structural and functional studies extended by the sca...

    Call: PRELUDIUM 20 , Panel: NZ7

    Principal investigator: Katarzyna Pacyga-Prus

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  12. New type of analogs and conjugates of folic acid with potential therapeutic applicaton in treatment of hormone-dependent...

    Call: PRELUDIUM 20 , Panel: NZ7

    Principal investigator: Olga Ciupak

    Politechnika Gdańska, Wydział Chemiczny

  13. Evaluation of NOTCH1- and NOTCH3-dependent anticancer drug resistance in a 2D and 3D model of Head and Neck Squamous Cel...

    Call: PRELUDIUM 20 , Panel: NZ5

    Principal investigator: Joanna Kałafut

    Uniwersytet Medyczny w Lublinie

  14. New 3-methoxypropanamide derivatives in search of effective substances for the treatment of neurological diseases - epil...

    Call: PRELUDIUM 20 , Panel: NZ7

    Principal investigator: Marcin Jakubiec

    Uniwersytet Jagielloński, Collegium Medicum

  15. Development of new implantable drug forms, biodegradable nanofibers containing selected betulin derivatives in order to ...

    Call: OPUS 21 , Panel: NZ7

    Principal investigator: prof. Janusz Kasperczyk

    Śląski Uniwersytet Medyczny w Katowicach, Wydział Nauk Farmaceutycznych w Sosnowcu

  16. The origin, transformations and influence of particulate matter and selectedorganic compounds in the air of beauty salon...

    Call: OPUS 21 , Panel: ST10

    Principal investigator: dr Patrycja Rogula-Kopiec

    Instytut Podstaw Inżynierii Środowiska Polskiej Akademii Nauk

  17. Addressing the brain glioma temozolomide therapy limitations

    Call: OPUS 21 , Panel: NZ7

    Principal investigator: dr hab. Joanna Lewandowska-Łańcucka

    Uniwersytet Jagielloński, Wydział Chemii

  18. Blocking the TNF-TNFR2 interactions as a novel approach to the ovarian carcinoma treatment

    Call: OPUS 21 , Panel: NZ7

    Principal investigator: prof. Sylwia Rodziewicz-Motowidło

    Uniwersytet Gdański, Wydział Chemii

  19. Synthetic epidermal growth factor receptor inhibitor conjugated with nobel metal nanoparticles as a potential drug for t...

    Call: PRELUDIUM 20 , Panel: NZ7

    Principal investigator: Shaoshan Mai

    Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny

  20. Thrombin binding aptamer with expanded chemical diversity as potential anticoagulant and anticancer agent

    Call: OPUS 21 , Panel: NZ7

    Principal investigator: dr Weronika Kotkowiak

    Instytut Chemii Bioorganicznej Polskiej Akademii Nauk

  21. An innovative method of treating acute liver failure using amniotic stem cells isolated from the human placenta.

    Call: PRELUDIUM 20 , Panel: NZ7

    Principal investigator: Patrycja Wieczorek

    Śląski Uniwersytet Medyczny w Katowicach, Wydział Nauk Medycznych w Katowicach

  22. Influence of indyvidual low-dose radiosensitivity on the chemopotentiating effect of low-dose fractionated radiation in ...

    Call: PRELUDIUM BIS 2 , Panel: NZ5

    Principal investigator: dr hab. Dorota Słonina

    Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy, Oddział w Gliwicach

  23. Smart polymer delivery systems for photosensitizers to cancer cells

    Call: PRELUDIUM BIS 2 , Panel: NZ7

    Principal investigator: prof. Tomasz Gośliński

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  24. New generation teranostatic nanocarriers for detection, diagnosis andneuroprotective treatment of ischemic stroke brain ...

    Call: OPUS 20 , Panel: NZ7

    Principal investigator: prof. Piotr Warszyński

    Instytut Katalizy i Fizykochemii Powierzchni im. Jerzego Habera Polskiej Akademii Nauk

  25. Design of chemical composition and thermal treatment for a new precipitation hardened aluminum alloy with enhanced stren...

    Call: SONATA 16 , Panel: ST5

    Principal investigator: dr Witold Chromiński

    Politechnika Warszawska, Wydział Inżynierii Materiałowej

  26. A novel approach based on the optimized multidrug combination for glioblastoma treatment.

    Call: SONATA 16 , Panel: NZ7

    Principal investigator: dr Małgorzata Kucińska

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  27. High Entropy Alloys in water vapor - optimization of high-temperature corrosion resistance for modern applications.

    Call: OPUS 20 , Panel: ST8

    Principal investigator: dr Wojciech Nowak

    Politechnika Rzeszowska im. Ignacego Łukasiewicza, Wydział Budowy Maszyn i Lotnictwa

  28. Synergism of strengthening with mineral halloysite nanotubes and with heat treatment of the newly developed composite ma...

    Call: OPUS 2 , Panel: ST8

    Principal investigator: prof. Leszek Dobrzański

    Politechnika Śląska, Wydział Mechaniczny Technologiczny

  29. The role of gut microbiota metabolite, trimethylamine N-oxide, in development of insulin resistance

    Call: PRELUDIUM BIS 2 , Panel: NZ7

    Principal investigator: dr hab. Robert Olek

    Akademia Wychowania Fizycznego im. Eugeniusza Piaseckiego w Poznaniu

  30. Assessment of the possibility of using vitamin D3 in the prevention and treatment of pulmonary fibrosis in the course of...

    Call: SONATA BIS 10 , Panel: NZ7

    Principal investigator: dr hab. Marta Lemieszek

    Instytut Medycyny Wsi im. Witolda Chodźki

  31. New 5-HT6 receptor ligands from the group of sulfonamide derivatives of cyclic arylguanidines in the treatment of gliobl...

    Call: PRELUDIUM 19 , Panel: NZ7

    Principal investigator: Przemysław Zaręba

    Politechnika Krakowska im. Tadeusza Kościuszki, Wydział Inżynierii i Technologii Chemicznej

  32. Microenvironment dependent disruption of tumor capillaries using diamond nanoparticles in treatment of highly vasculariz...

    Call: OPUS 19 , Panel: NZ7

    Principal investigator: dr Mateusz Wierzbicki

    Szkoła Główna Gospodarstwa Wiejskiego w Warszawie, Instytut Biologii

  33. MODIFICATION OF HIGH NUTRITIONAL GLUTEN-FREE FLOURS BY INNOVATIVE HEAT-MOISTURE TREATMENT FOR THE DEVELOPMENT OF IMPROVE...

    Call: POLS , Panel: ST5

    Principal investigator: dr Marina Villanueva

    Uniwersytet Ekonomiczny we Wrocławiu, Wydział Inżynierii Produkcji

  34. Molecular mechanism underlying the anti-inflammatory action of CB2 receptor agonists in microglia: participation of the ...

    Call: OPUS 19 , Panel: NZ7

    Principal investigator: dr Natalia Małek-Chudzik

    Politechnika Wrocławska

  35. Photodynamic therapy combined with PD-1/PD-L1 blockade immunotherapy: new possibilities for the treatment of immunogenic...

    Call: OPUS 19 , Panel: NZ7

    Principal investigator: dr hab. Janusz Dąbrowski

    Uniwersytet Jagielloński, Wydział Chemii

  36. Dual CBR1-AKR1C3 inhibitors as a new approach to improve effectiveness and safety of anthracycline therapy.

    Call: PRELUDIUM 19 , Panel: NZ7

    Principal investigator: Marek Jamrozik

    Uniwersytet Jagielloński, Collegium Medicum

  37. Evaluation of the potential use of noble metal nanoparticles as drug delivery platforms in an experimental model of infl...

    Call: PRELUDIUM 19 , Panel: NZ7

    Principal investigator: Karol Steckiewicz

    Gdański Uniwersytet Medyczny, Wydział Lekarski

  38. The role of RNA methylation in pathogenesis of head and neck squamous cell carcinoma

    Call: PRELUDIUM 19 , Panel: NZ5

    Principal investigator: Kamila Romanowska

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  39. Analysis of the cognitive-behavioral dysfunctions profile and the potential of neuroplasticity in patients with brain tu...

    Call: OPUS 19 , Panel: NZ7

    Principal investigator: dr hab. Katarzyna Hojan

    Wielkopolskie Centrum Onkologii im. Marii Skłodowskiej-Curie

  40. Novel approach in the search for asthma and COPD therapies - computer aided design of multi-target-directed ligands bloc...

    Call: PRELUDIUM 19 , Panel: NZ7

    Principal investigator: Alicja Gawalska

    Uniwersytet Jagielloński, Collegium Medicum

  41. Towards innovative strategy for treatment of Alzheimer's Disease via dual inhibition of receptor 5-HT6 and kinase CDK5.

    Call: PRELUDIUM 19 , Panel: NZ7

    Principal investigator: Sylwia Sudoł

    Uniwersytet Jagielloński, Collegium Medicum

  42. Combined administration of muscarinic receptor antagonists and group II/III metabotropic glutamate (mGlu) receptor ligan...

    Call: OPUS 19 , Panel: NZ7

    Principal investigator: prof. Andrzej Pilc

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  43. Dual histamine H3 and sigma-1 receptor ligands as novel pharmacological tools in the treatment of central nervous system...

    Call: SONATINA 4 , Panel: NZ7

    Principal investigator: Katarzyna Szczepańska

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  44. New iron chelators from thiosemicarbazone group in photodynamic therapy

    Call: PRELUDIUM 18 , Panel: NZ7

    Principal investigator: Robert Gawecki

    Uniwersytet Śląski w Katowicach, Wydział Nauk Ścisłych i Technicznych

  45. Individual biological response of breast cancer tumours to proton irradiation in correlation with molecular and microenv...

    Call: OPUS 18 , Panel: NZ7

    Principal investigator: prof. Julian Malicki

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  46. Investigation of molecular mechanisms of rapid antidepressant action of NLX-101, a biased agonist of the 5-HT1A receptor...

    Call: OPUS 18 , Panel: NZ7

    Principal investigator: prof. Mariusz Papp

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  47. Physical exercise as a natural mechanism inducing neuroregeneration. Search for the new protein markers and therapeutic ...

    Call: OPUS 18 , Panel: NZ7

    Principal investigator: dr hab. Katarzyna Kuter

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  48. Modulation of exosome production to support anti-cancer treatment

    Call: OPUS 18 , Panel: NZ7

    Principal investigator: dr hab. Markus Düchler

    Centrum Badań Molekularnych i Makromolekularnych Polskiej Akademii Nauk

  49. Defining the contribution of Bmi1-positive oral epithelial stem cells in the process of tumorgenesis using lineage traci...

    Call: PRELUDIUM 18 , Panel: NZ5

    Principal investigator: Kamila Karpińska

    Uniwersytet Warszawski, Centrum Nowych Technologii Uniwersytetu Warszawskiego

  50. Pharmacological modulation of histamine H3 and H4 receptors - a new perspective in the treatment of neuropathic pain

    Call: SONATA 15 , Panel: NZ7

    Principal investigator: dr Katarzyna Popiołek-Barczyk

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk